memantine-niacin prodrug (Lijun International Pharmaceutical)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namememantine-niacin prodrug (Lijun International Pharmaceutical)
Drug Alias NameMeN061016-1
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsAlzheimer DiseaseDementia, Vascular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShisiyao Group Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShisiyao Group Co Ltd
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseDementia, Vascular

Other Information

ATC CodeN/A
Related LinksN/A